Deutsche Bank sets $31 target for Denali Therapeutics stock
Deutsche Bank (ETR:DBKGn) initiated coverage on Denali Therapeutics Inc. (NASDAQ: NASDAQ:DNLI) with a Buy rating and set a price target of $31.00. The new assessment comes as Denali's shares are seen ...
Alaska Public Media14d
Denali or McKinley: What should the mountain be called and why does it matter?
President Trump has ordered the name of North America's tallest peak to revert from Denali to its former name: Mount McKinley ...
Stifel maintains Buy on Denali Therapeutics, $37 target
Stifel analysts confirmed their Buy rating on Denali Therapeutics Inc. (NASDAQ:DNLI) with a steady price target of $37.00. According to InvestingPro data, analysts maintain a Strong Buy consensus with ...
SG Americas Securities LLC Acquires 6,195 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)
SG Americas Securities LLC increased its holdings in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 128.8% in the 4th quarter, according to the company in its most recent filing ...
Forbes21d
Trump Renames Denali To Mount McKinley—Here’s What To Know
President Donald Trump signed an executive order Monday renaming Denali—the highest peak in North America—to Mount McKinley, the Alaska mountain’s name prior to 2015, a move he has suggested ...
ETF Daily News11d
Denali Therapeutics (NASDAQ:DNLI) Price Target Cut to $40.00 by Analysts at The Goldman Sachs Group
Denali Therapeutics (NASDAQ:DNLI – Free Report) had its target price trimmed by The Goldman Sachs Group from $45.00 to $40.00 in a research report sent to investors on Tuesday morning ...